Cobicistat
From Proteopedia
(Difference between revisions)
| Line 2: | Line 2: | ||
Cobicistat, sold under the brand name Tybost, is a medication for use in the treatment of human immunodeficiency virus infection (HIV/AIDS). Its major mechanism of action is through the inhibition of human CYP3A proteins. | Cobicistat, sold under the brand name Tybost, is a medication for use in the treatment of human immunodeficiency virus infection (HIV/AIDS). Its major mechanism of action is through the inhibition of human CYP3A proteins. | ||
| - | <scene name='98/989322/Cv/2'>Complex of CYP3A4 with a desoxyritonavir analog</scene> ([[4k9t]]). | + | <scene name='98/989322/Cv/2'>Complex of CYP3A4 with a desoxyritonavir analog</scene> ([[4k9t]]). <scene name='98/989322/Cv/3'>TextToBeDisplayed</scene> |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 11:35, 30 August 2023
| |||||||||||
